|
Volumn 99, Issue 9, 2004, Pages 1641-1644
|
Malpractice risks associated with colon cancer and inflammatory bowel disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
STEROID;
CANCER RISK;
CANCER SCREENING;
CLINICAL PRACTICE;
COLON CANCER;
COLONOSCOPY;
DIAGNOSTIC ERROR;
DISEASE ASSOCIATION;
ENTERITIS;
EVIDENCE BASED MEDICINE;
EXPERT WITNESS;
GENETIC RISK;
HEALTH INSURANCE;
HUMAN;
INFORMED CONSENT;
LABORATORY TEST;
LAW SUIT;
LEGAL LIABILITY;
MALPRACTICE;
MEDICAL DOCUMENTATION;
MEDICAL EDUCATION;
MEDICAL LIABILITY;
MEDICAL SPECIALIST;
MEDICOLEGAL ASPECT;
NEGLIGENCE;
PATIENT;
PERFORMANCE;
PHYSICIAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY CONTROL;
REVIEW;
RISK ASSESSMENT;
STANDARD;
THEORETICAL STUDY;
COLORECTAL NEOPLASMS;
DIAGNOSTIC ERRORS;
FEMALE;
HUMANS;
INCIDENCE;
INFLAMMATORY BOWEL DISEASES;
LIABILITY, LEGAL;
MALE;
MALPRACTICE;
MASS SCREENING;
PRACTICE GUIDELINES;
RISK FACTORS;
RISK MANAGEMENT;
UNITED STATES;
|
EID: 4544294882
PISSN: 00029270
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1572-0241.2004.40943.x Document Type: Review |
Times cited : (21)
|
References (19)
|